Kreutzman, Anna <br/><br/>
Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2017 
 - 6697-6707 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-16-0667  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Cell Line, Tumor<br/>Dasatinib--administration & dosage<br/>Endothelial Cells--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Mice<br/>Molecular Motor Proteins--agonists<br/>Myosin Heavy Chains<br/>Wound Healing--drug effects<br/>Xenograft Model Antitumor Assays<br/>rho-Associated Kinases--genetics